Personal information

Other IDs

Scopus Author ID: 57216837810

Keywords

SZAOK, ASZMS

Activities

Collapse all

Employment (1)

Szent-Györgyi Albert Medical School, University of Szeged: Szeged, HU

2021-09-01 to present (Department of Gastroenterology)
Employment
Source: Self-asserted source
Péter Bacsur

Works (26)

Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum

Inflammatory Bowel Diseases
2025-03-03 | Journal article
DOI: 10.1093/ibd/izae167
Contributors: Bernadett Farkas; Emese Ivány; Anita Bálint; Peter Bacsur; Tamás Molnár; Klaudia Farkas
Source: check_circle
Crossref

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype? Authors' Reply

Alimentary Pharmacology & Therapeutics
2025-01 | Journal article
DOI: 10.1111/apt.18427
Contributors: Péter Bacsur; Klaudia Farkas; Tamás Molnár
Source: check_circle
Crossref

Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study

Alimentary Pharmacology & Therapeutics
2025-01 | Journal article
DOI: 10.1111/apt.18359
Contributors: Péter Bacsur; Daniel Shaham; Zuzana Serclova; Tamás Resál; Bernadett Farkas; Patrícia Sarlós; Pál Miheller; Nitsan Maharshak; Meir Zemel; Ariella Bar‐Gil Shitrit et al.
Source: check_circle
Crossref

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply

Alimentary Pharmacology & Therapeutics
2025-01 | Journal article
DOI: 10.1111/apt.18432
Contributors: Péter Bacsur; Klaudia Farkas; Tamás Molnár
Source: check_circle
Crossref

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease: A Retrospective, Multicentre Study

Journal of Clinical Medicine
2024-12 | Journal article | Author
DOI: 10.3390/jcm13247804
Contributors: Bernadett Farkas; Talat Bessissow; Jimmy K. Limdi; Karishma Sethi-Arora; Анна Каграманова; Oleg Knyazev; Cristina Bezzio; Alessandro Armuzzi; Milan Lukas; George Michalopoulos et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn’s Disease

Biomedicines
2024-09-14 | Journal article
DOI: 10.3390/biomedicines12092100
Contributors: Péter Bacsur; Tamás Resál; Bernadett Farkas; Boldizsár Jójárt; Zoltán Gyuris; Gábor Jaksa; Lajos Pintér; Bertalan Takács; Sára Pál; Attila Gácser et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

Journal of Crohn's and Colitis
2024-03-01 | Journal article
DOI: 10.1093/ecco-jcc/jjad160
Contributors: Boldizsár Jójárt; Tamás Resál; Diána Kata; Tünde Molnár; Péter Bacsur; Viktória Szabó; Árpád Varga; Kata Judit Szántó; Petra Pallagi; Imre Földesi et al.
Source: check_circle
Crossref

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241239606
Contributors: Péter Bacsur; Panu Wetwittayakhlang; Tamás Resál; Emese Földi; Béla Vasas; Bernadett Farkas; Mariann Rutka; Talat Bessissow; Waqqas Afif; Anita Bálint et al.
Source: check_circle
Crossref

Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for pancreaticobiliary cytopathology in solid pancreatic lesions

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241271958
Contributors: Béla Vasas; Anna Fábián; Zsófia Bősze; Sándor Hamar; László Kaizer; Tibor Tóth; Péter Bacsur; Tamás Resál; Anita Bálint; Klaudia Farkas et al.
Source: check_circle
Crossref

Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241290636
Contributors: Péter Bacsur; Tamás Resál; Patrícia Sarlós; Ákos Iliás; Liza Dalma Sümegi; Diána Kata; Anett Dávid; Bernadett Farkas; Emese Ivány; Anita Bálint et al.
Source: check_circle
Crossref

Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions

Diagnostics
2023-09 | Journal article | Author
DOI: 10.3390/diagnostics13172841
Contributors: Renáta Bor; Béla Vasas; Anna Fábián; Mónika Szűcs; Zsófia Bősze; Anita Bálint; Mariann Rutka; Klaudia Farkas; Tibor Toth; Tamás Resál et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary

Alimentary Pharmacology & Therapeutics
2023-07 | Journal article
DOI: 10.1111/apt.17610
Contributors: Péter Bacsur; Ákos Iliás; Tamás Resál; Diána Kata; Tamás Molnár; Klaudia Farkas
Source: check_circle
Crossref

Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

Expert Opinion on Drug Safety
2023-06-03 | Journal article
DOI: 10.1080/14740338.2023.2181336
Contributors: Tamás Resál; Katalin Mangó; Péter Bacsur; Kata Szántó; Daniella Pigniczki; Csilla Keresztes; Mariann Rutka; Anita Bálint; Ágnes Milassin; Renáta Bor et al.
Source: check_circle
Crossref

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

Therapeutic Advances in Gastroenterology
2023-01 | Journal article
DOI: 10.1177/17562848231174298
Contributors: Péter Bacsur; Mariann Rutka; András Asbóth; Tamás Resál; Kata Szántó; Boldizsár Jójárt; Anita Bálint; Eszter Ari; Walliyulahi Ajibola; Bálint Kintses et al.
Source: check_circle
Crossref

Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

Therapeutic Advances in Gastroenterology
2023-01 | Journal article
DOI: 10.1177/17562848231183529
Contributors: Tamás Resál; Péter Bacsur; Miklós Horváth; Kata Szántó; Mariann Rutka; Anita Bálint; Anna Fábián; Renáta Bor; Zoltán Szepes; János Fekete et al.
Source: check_circle
Crossref

Conception and reality: Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments.

Vaccine: X
2022-12-22 | Journal article
DOI: 10.1016/j.jvacx.2022.100253
PMID: 36573242
PMC: PMC9773695
Contributors: Resál T; Matuz M; Keresztes C; Bacsur P; Szántó K; Sánta A; Rutka M; Kolarovszki-Erdei D; Bor R; Fábián A et al.
Source: Self-asserted source
Péter Bacsur

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.

Journal of Crohn's & colitis
2022-12-01 | Journal article
DOI: 10.1093/ecco-jcc/jjac100
PMID: 35895074
Contributors: Yanai H; Kagramanova A; Knyazev O; Sabino J; Haenen S; Mantzaris GJ; Mountaki K; Alessandro Armuzzi; Pugliese D; Furfaro F et al.
Source: Self-asserted source
Péter Bacsur

Infection risk related to gastrointestinal endoscopic procedures during the SARS-CoV-2 pandemic

Orvosi hetilap
2022-11-13 | Journal article
DOI: 10.1556/650.2022.32633
PMID: 36373579
Contributors: Fábián A; Bor R; Tóth T; Bacsur P; Bálint A; Farkas K; Milassin Á; Molnár T; Resál T; Rutka M et al.
Source: Self-asserted source
Péter Bacsur

Appendiceal Mucinous Neoplasm Appearance on NBI Colonoscopy.

Journal of gastrointestinal and liver diseases : JGLD
2022-09-15 | Journal article
DOI: 10.15403/jgld-4478
PMID: 36112708
Contributors: Bacsur P; Tamás Resál; Farkas K; Ábrahám S; Tamás Molnár
Source: Self-asserted source
Péter Bacsur

Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients.

Journal of Crohn's & colitis
2022-06-01 | Journal article
DOI: 10.1093/ecco-jcc/jjab207
PMID: 34792132
PMC: PMC9228885
Contributors: Bacsur P; Farkas K; Molnar T
Source: Self-asserted source
Péter Bacsur

The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease.

Frontiers in nutrition
2022-04-25 | Journal article
DOI: 10.3389/fnut.2022.718710
PMID: 35548572
PMC: PMC9082752
Contributors: Inczefi O; Bacsur P; Resál T; Keresztes C; Molnár T
Source: Self-asserted source
Péter Bacsur

Area of the IBD Disk Correlated Strongly with Disease Activity Compared with the Conventionally Used IBD Disk Score.

Journal of Crohn's & colitis
2022-02-01 | Journal article
DOI: 10.1093/ecco-jcc/jjab138
PMID: 34329410
PMC: PMC8864629
Contributors: Bacsur P; Farkas K; Molnar T
Source: Self-asserted source
Péter Bacsur

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Therapeutic Advances in Gastroenterology
2022-01 | Journal article
DOI: 10.1177/17562848221144349
Contributors: Péter Bacsur; Mária Matuz; Tamás Resál; Pál Miheller; Tamás Szamosi; Eszter Schäfer; Patrícia Sarlós; Ákos Iliás; Kata Szántó; Mariann Rutka et al.
Source: check_circle
Crossref

Double Stenting for Malignant Biliary and Duodenal Obstruction: A Systematic Review and Meta-Analysis

Clinical and translational gastroenterology
2020 | Journal article
DOI: 10.14309/ctg.0000000000000161
EID:

2-s2.0-85084920543

Part of ISSN: 2155384X
Contributors: Fábián, A.; Bor, R.; Gede, N.; Bacsur, P.; Pécsi, D.; Hegyi, P.; Tóth, B.; Szakács, Z.; Vincze, Á.; Ruzsics, I. et al.
Source: Self-asserted source
Péter Bacsur via Scopus - Elsevier

Long-term follow-up of inflammatory bowel disease patients receiving anti-tumor necrosis factor-alpha therapy,Anti-TNFα-terápiában részesülő gyulladásos bélbetegek hosszú távú utánkövetése

Orvosi hetilap
2020 | Journal article
DOI: 10.1556/650.2020.31913
EID:

2-s2.0-85096814081

Part of ISSN: 17886120
Contributors: Bacsur, P.; Skribanek, S.; Milassin, Á.; Farkas, K.; Bor, R.; Fábián, A.; Rutka, M.; Bálint, A.; Szántó, K.J.; Tóth, T. et al.
Source: Self-asserted source
Péter Bacsur via Scopus - Elsevier

Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome

Pharmaceuticals
2020-10 | Journal article | Author
DOI: 10.3390/ph13110346
Contributors: Anita Bálint; Klaudia Farkas; Orsolya Méhi; Bálint Kintses; Balint Mark Vasarhelyi; Eszter Ari; Csaba Pál; Tamara Madacsy; József Maléth; Kata Judit Szántó et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Peer review (4 reviews for 1 publication/grant)

Review activity for Digestive and Liver Disease. (4)
How many people are using ORCID?